Back to top

Analyst Blog

Cerner Corp. (CERN - Analyst Report) has deployed a new mobility and communications solution named CareAware Connect for clinicians using smart phone devices. This positive news should further boost investor confidence on the stock, which has already risen 4% since Oct 1.

CareAware Connect is a clinical mobility solution, which allows clinicians to communicate as well as access electronic health record (EHR) data and alerts on their smart phones. It has been initially designed to run on the Apple iPhone. Cerner has successfully set up this new tool for clinicians at Fisher-Titus Medical Center in Norwalk, Ohio, and the NCH Healthcare System in Naples, FL.

Management asserts that CareAware Connect is a fast, easy and smart tool, enabling smooth coordination between medical devices, health care applications and EHR systems. Some of the special features of this advanced mobile solution include voice calls within as well as outside clinical settings, secure messaging amongst caregivers, and review EHR data and alerts on smarphones. Cerner plans to further expand CareAware Connect to physicians and add bar-code enabled workflows in future versions.

Although the new product is expected to accelerate CERN’s top-line growth, we are cognizant of stiff competition in the underlying market. Recently, Cerner’s peer, athenahealth (ATHN - Analyst Report) launched a new mobile application (app), "Epocrates Bugs + Drugs," which combines cloud-based clinical data with a user-friendly mobile interface.

Moreover, Quality Systems (QSII - Analyst Report) and ITelagen has launched NextGenAnywhere, a technology that delivers the NextGen Ambulatory EHR to mobile devices. Available for iPad and Android tablet mobile devices, NextGenAnywhere is powered by ITelagen's innovative EHRAnywhere platform to enable physicians the freedom and flexibility to access patient medical data and applications.

Cerner presently has a Zacks Rank #3 (Hold). While we choose to remain on the sidelines regarding CERN, medical stock Cardinal Health, Inc. (CAH - Analyst Report) carrying a Zacks Rank #1 (Strong Buy), warrants a look.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%